WEC
LUMO

Winslow Evans & Crocker’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Winslow Evans & Crocker’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-133
Closed -$2K – 1360
2018
Q4 		$2K Hold
133
– – ﹤0.01% 1068
2018
Q3 		$4K Hold
133
– – ﹤0.01% 988
2018
Q2 		$6K Hold
133
– – ﹤0.01% 931
2018
Q1 		$8.7K Buy
+133
New +$9.42K ﹤0.01% 815
2014
Q1 		– Sell
-68
Closed -$13K – 1407
2013
Q4 		$13K Buy
+68
New +$12.1K ﹤0.01% 831

Other funds holding LUMO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Winslow Evans & Crocker's LUMO Position: Q1 2019 in Review

Winslow Evans & Crocker sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2019, closing a stake of 133 shares — an estimated $2K sold.

Winslow Evans & Crocker first reported a position in LUMO in Q4 2013 and held it in 5 quarters. The position peaked at $13K in Q4 2013. 82 funds tracked by Wall St. Rank hold LUMO as of Q1 2019.

  • Winslow Evans & Crocker reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Winslow Evans & Crocker sold 133 Lumos Pharma, Inc. Common Stock shares in Q1 2019, an estimated $2K.
  • Winslow Evans & Crocker first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2013 and held it in 5 quarters.
  • Winslow Evans & Crocker's Lumos Pharma, Inc. Common Stock position peaked at $13K in Q4 2013.
  • 82 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2019.

Based on Winslow Evans & Crocker's 13F filing for Q1 2019, filed 22 Apr 2019.